Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

BUY
$231.06 - $307.08 $478,294 - $635,655
2,070 New
2,070 $501,000
Q4 2020

Feb 16, 2021

SELL
$110.06 - $133.7 $733,219 - $890,709
-6,662 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$99.78 - $124.21 $267,410 - $332,882
-2,680 Reduced 28.69%
6,662 $790,000
Q2 2020

Aug 14, 2020

BUY
$60.13 - $125.71 $561,734 - $1.17 Million
9,342 New
9,342 $1.06 Million

Others Institutions Holding MDGL

About MADRIGAL PHARMACEUTICALS, INC.


  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $5.77B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Quantitative Investment Management, LLC Portfolio

Follow Quantitative Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantitative Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quantitative Investment Management, LLC with notifications on news.